Sinclair Pharma acquires remaining 49.95% stake in Laboratorios Novo Pharma - MarketLine Financial Deals

Sinclair Pharma acquires remaining 49.95% stake in Laboratorios Novo Pharma

Sinclair Pharma acquires remaining 49.95% stake in Laboratorios Novo Pharma - MarketLine Financial Deals
Sinclair Pharma acquires remaining 49.95% stake in Laboratorios Novo Pharma
Published Feb 04, 2009
1 pages — Published Feb 04, 2009
Price US$ 45.00  |  Buy this Report Now

About This Report

  
Abstract:

Sinclair Pharma plc, a UK-based specialty pharmaceutical company, has acquired the remaining 49.95% stake in Laboratorios Novo Pharma S.L. (LNP), a Spain-based company engaged in the manufacturing and marketing of cosmetics and food supplements, from LNP's management for EUR0.33 million.

  
Source:
Document ID
MA01509_090209
Country
Country
Ticker
SPH=GB
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Sinclair Pharma acquires remaining 49.95% stake in Laboratorios Novo Pharma" Feb 04, 2009. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Sinclair-Pharma-acquires-remaining-49-95-stake-in-Laboratorios-Novo-Pharma-2052-1441>
  
APA:
MarketLine Financial Deals. (2009). Sinclair Pharma acquires remaining 49.95% stake in Laboratorios Novo Pharma Feb 04, 2009. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Sinclair-Pharma-acquires-remaining-49-95-stake-in-Laboratorios-Novo-Pharma-2052-1441>
  
US$ 45.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.